NOTIFICATION OF MAJOR HOLDINGS |
|
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
BioPharma Credit PLC |
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) |
Non-UK issuer |
|
2. Reason for the notification (please mark the appropriate box or boxes with an "X") |
An acquisition or disposal of voting rights |
YES |
An acquisition or disposal of financial instruments |
NO |
An event changing the breakdown of voting rights |
NO |
Other (please specify): |
NO |
3. Details of person subject to the notification obligation |
Name |
Adage Capital Partners GP LLC |
City and country of registered office (if applicable) |
Boston, MA USA |
4. Full name of shareholder(s) (if different from 3.) |
Name |
Morgan Stanley & Co LLC GB00BDGKMY29 common stock 25,284.247 JP Morgan Securities LLC GB00BDGKMY29 common stock 8,500,000 GB00BDRNW621 common stock 66,000,000 |
City and country of registered office (if applicable) |
New York, NY USA |
5. Date on which the threshold was crossed or reached: |
13/04/2018 |
6. Date on which issuer notified (DD/MM/YYYY): |
22/05/2018 |
7. Total positions of person(s) subject to the notification obligation |
|
% of voting rights attached to shares (total of 8. A) |
% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2) |
Total of both in % (8.A + 8.B) |
Total number of voting rights of issuer |
Resulting situation on the date on which threshold was crossed or reached |
9.25% |
|
9.25% |
1,078,035,138 |
Position of previous notification (if applicable) |
3.32% |
|
3.32% |
|
| |
|
|
|
|
|
|